- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Predicting tumour content of liquid biopsies from cell-free DNA ; volume:24 ; number:1 ; day:30 ; month:9 ; year:2023 ; pages:1-9 ; date:12.2023
BMC bioinformatics ; 24, Heft 1 (30.9.2023), 1-9, 12.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Cardner, Mathias
Marass, Francesco
Gedvilaite, Erika
Yang, Julie L.
Tsui, Dana W. Y.
Beerenwinkel, Niko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-023-05478-8
- URN
-
urn:nbn:de:101:1-2024020515415926360674
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cardner, Mathias
- Marass, Francesco
- Gedvilaite, Erika
- Yang, Julie L.
- Tsui, Dana W. Y.
- Beerenwinkel, Niko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Liquid biopsies: tumour diagnosis and treatment monitoring
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Emerging concepts in liquid biopsies
Liquid biopsies and cancer omics
Liquid biopsies and cancer omics
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications
Proteomics technologies for cancer liquid biopsies
Liquid biopsies to occult brain metastasis
The Translational Status of Cancer Liquid Biopsies
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
Liquid biopsies: tumour diagnosis and treatment monitoring
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Emerging concepts in liquid biopsies
Liquid biopsies and cancer omics
Liquid biopsies and cancer omics
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications
Proteomics technologies for cancer liquid biopsies
Liquid biopsies to occult brain metastasis
The Translational Status of Cancer Liquid Biopsies
Predicting response to neoadjuvant chemotherapy with liquid biopsies and multiparametric MRI in patients with breast cancer
Liquid biopsies: tumour diagnosis and treatment monitoring
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Emerging concepts in liquid biopsies
Liquid biopsies and cancer omics
Liquid biopsies and cancer omics
MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies
Cancer liquid biopsies by Oxford Nanopore Technologies sequencing of cell-free DNA: from basic research to clinical applications
Proteomics technologies for cancer liquid biopsies
Liquid biopsies to occult brain metastasis
The Translational Status of Cancer Liquid Biopsies